Literature DB >> 11822579

Age-specific levels of diabetes-related GAD and IA-2 antibodies in healthy children and adults.

Olga Kordonouri1, Reinhard Hartmann, Anette Grüters-Kieslich, Mikael Knip, Thomas Danne.   

Abstract

Glutamic acid decarboxylase (GAD) and tyrosine phosphatase IA-2 antibody levels were measured in 375 healthy children and adults and in 187 children with newly diagnosed type 1 diabetes mellitus (DM). GAD antibody levels were determined by radioimmunoassay, and IA-2 antibody levels by immunoprecipitation. Healthy children had higher GAD antibody levels than adults (p < 0.001). The 98th percentile was 1.60 U/ml in children and 1.16 U/ml in adults. IA-2 antibody levels did not differ between these two cohorts. Children with DM had higher GAD and IA-2 antibody levels than healthy children (p <0.001). Based on receiver operating characteristics (ROC) analysis, elevated levels of these antibodies showed high specificity rates (+/- SE) of 0.968 +/- 0.14 to 1.00 +/- 0.00. The sensitivity ranged between 0.439 +/- 0.037 (both antibodies elevated) and 0.850 +/- 0.027 (at least one antibody elevated). These data emphasize the importance of establishing age-specific reference values for DM-related antibodies in the background population before applying them for screening and intervention studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822579     DOI: 10.1515/jpem.2002.15.1.47

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus.

Authors:  Young Hwa Kong; Min Sun Kim; Dae-Yeol Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-06-30

2.  Most Women with Previous Gestational Diabetes Mellitus Have Impaired Glucose Metabolism after a Decade.

Authors:  Jeanette Wahlberg; Bertil Ekman; Hans J Arnqvist
Journal:  Int J Mol Sci       Date:  2018-11-23       Impact factor: 5.923

3.  Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD).

Authors:  Tor-Arne Hegvik; Eystein S Husebye; Jan Haavik
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-05-28       Impact factor: 4.785

4.  The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults.

Authors:  Eunhee G Kim; Soo Heon Kwak; Daehee Hwang; Eugene C Yi; Kyong Soo Park; Bo Kyung Koo; Kristine M Kim
Journal:  Diabetes Metab J       Date:  2016-04       Impact factor: 5.376

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.